HK inno.N Corporation Stock: price and insider trades · South Korea

HK inno.N Corporation is a Health Care company. Its directors and officers file their transactions with DART (FSS). Over the twelve months to 18 October 2026, the company's managers filed 8 filings, from 7 insiders.

On the market, 5 insiders bought (6 purchases totalling €157k) while 1 insider sold (1 sale). The totals do not cover 4 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 senior executives and 1 chief executive. The largest single trade was a purchase of €57k by 윤상현, published on 20 April 2026, equal to 0.0079% of the market capitalisation.

In all, 2 purchases were made within 30 days of a purchase by another insider of the company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 22 April 2026, which is 179 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 1 day. Until a filing is published, the market cannot know about the trade.

Across the 2,648 companies tracked on its exchange, the median is 7 filings; at 8 filings, this issuer sits above that mark. The full history, which starts in 2021, counts 14 purchases against 17 sales.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.